GSA Summer Meeting
July 13-15, 2018
Program & Agenda

*subject to change

 

Friday | Saturday | Sunday

Friday, July 13

3:00 - 7:00p

Registration
Location:RCBR Foyer

4:00 - 9:00p

Exhibit Assembly
Location: Salon III

5:00 - 7:00p

Board of Directors Meeting
Location: Sassafras

7:00 - 8:30p

Welcome Hospitality with Exhibitors
Location: Salon III

8:30p

Dinner on Your Own

Saturday, July 14

6:00a

Exhibit Assembly
Location: Salon III

6:30 - 7:20a

Registration
Location: RCBR Foyer

Breakfast with Exhibitors
Location: Salon III

All session to take place in Salon I&II unless otherwise noted

7:20 – 7:30a

Welcome
Introductions 
Shvetank Agarwal, MD, FASE and Ed Foley, MD, GSA 2018 Activity Directors

7:30 - 8:30a

Updates from the ASA
James Grant, MD, MBA, FASA, ASA President

At the end of the session, participants will understand:

  1. Key trends and challenges facing the specialty in the market, legislature and regulatory, nationally and in the states
  2. Future of healthcare and future of anesthesiology specialty
  3. How ASA is working with members nationally and in the states to address current and emerging opportunities

8:30 - 9:30a

History of Anesthesiology and the GSA
William Hammonds, MD, MPH, Emeritus Professor of Anesthesiology, Emory University

9:30 - 10:00a

Break with Exhibitors
Location: Salon III

9:30 - 11:00a

Resident Section Meeting
Location: Meadowlark

10:00 - 11:00a

Ketamine/Propofol Admixture:  Results from a Randomized Controlled Trial in the Critically Ill
Nathan J. Smischney, MD, Mayo Clinic

At the end of the session, participants will be able to:

  1. Describe the “ketofol” concept
  2. Become familiar with the evidence surrounding post-intubation hypotension and the potential negative impact on patient-related outcomes
  3. Recognize the drawbacks with the use of etomidate and/or ketamine in the critically and non-critically ill
  4. Become familiar with the results of the KEEP PACE trial and how the results may help with patient care in the OR

11:00a – 12:00p

Prescriptive Analytics and Pharmacogenomics – the new paradigm to perioperative opioid administration and pain management
Mark Ereth, MD, Mayo Clinic

At the end of the session, participants will be able to:

  1. Review current opioid prescribing
  2. Understand the importance of Pharmacogenomic Testing with Opioid Therapy
  3. Appreciate development of Precision Analgesic Regimen

11:00a - 1:00p

GA-AAA General Body Meeting
Location: Osprey

12:00 - 1:00p

Poster Presentation Moderation
Shvetank Agarwal, MD, FASE and Ed Foley, MD, GSA 2018 Activity Directors
Location: RCBR Foyer

1:00p

Meeting Adjourned/Family Fun Time

4:00 - 5:00p

Family Fun Time Ice Cream Social

*Sponsored by GA-AAA
Location: Tupelo

5:00 – 6:00p

Committee Meetings

  • Government Affairs - Sassafras
  • Practice Management - Meadowlark
  • Membership - Osprey
  • Program and Education - Loblolly

6:00p

Governance Assembly (Committee Reports)

6:00 - 6:30p

Residents, CAA, SAA Reception
Location: Flag Stone Patio

6:30 - 8:00p

70th Anniversary Recognition Banquet
*This is a ticketed event.  Additional registration is required.
Location: The Pavilion

Sunday, July 15

6:30a - 7:30a 

Breakfast with Exhibitors
Location: Salon III

7:00a - 7:30a

General Business Meeting for GSA Members

7:30a - 8:30a

LVADs and Noncardiac Surgery: What to Do When They Come to Your OR             
Mark Ereth, MD, Mayo Clinic

At the end of the session, participants will be able to:

  1. Review LVAD therapy update
  2. How to manage LVAD patients under general anesthesia

8:30a - 9:30a

Perioperative Broken Heart Syndrome - Implications for the General Anesthesiologist
Manuel Castresana, MD, FCCM, FASA, Augusta University

At the end of the session, participants will be able to:

  1. Define Takotsubo Cardyomyopathy
  2. Review the incidence and risk factors during the perioperative period
  3. Discuss treatment options

9:30a – 10:00a

Break with Exhibitors
Location: Salon III

10:00a – 11:00a

Shock Index and Modified Shock Index: here to stay or gone tomorrow?
Nathan J. Smischney, MD, Mayo Clinic

At the end of the session, participants will be able to:

  1. Recognize the drawbacks with the use of lactate as a resuscitation endpoint
  2. Describe shock and modified shock index and to identify when both are abnormal
  3. Become familiar with the evidence surrounding shock and modified shock index
  4. Describe how shock indices may guide the anesthesiologist in predicting hemodynamic collapse and to recognize its use as a resuscitation endpoint